Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Porcine cancer models for clinical translation

Nature Reviews Cancer volume 22, pages 375–376 (2022)Cite this article

Subjects

Complex therapies and multimodal interventions have become the gold standard approach for many of the most aggressive tumour types. However, there is a lack of models that enable the development and clinical translation of such treatment concepts. Can porcine cancer models fill the gap?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Porcine models can fill a major gap in the translational chain of cancer research.

References

  1. Kalla, D., Kind, A. & Schnieke, A. Genetically engineered pigs to study cancer. Int. J. Mol. Sci. 21, 488 (2020).

    Article  CAS  Google Scholar 

  2. Pabst, R. The pig as a model for immunology research. Cell Tissue Res. 380, 287–304 (2020).

    Article  Google Scholar 

  3. Callesen, M. M. et al. A genetically inducible porcine model of intestinal cancer. Mol. Oncol. 11, 1616–1629 (2017).

    Article  CAS  Google Scholar 

  4. Flisikowska, T. et al. A porcine model of familial adenomatous polyposis. Gastroenterology 143, 1173–1175 (2012).

    Article  CAS  Google Scholar 

  5. Rogalla, S. et al. Biodegradable fluorescent nanoparticles for endoscopic detection of colorectal carcinogenesis. Adv. Funct. Mater. 29, 1904992 (2019).

    Article  CAS  Google Scholar 

  6. Hendricks-Wenger, A. et al. Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation. Sci. Rep. 11, 7584 (2021).

    Article  CAS  Google Scholar 

  7. Boas, F. E. et al. Induction and characterization of pancreatic cancer in a transgenic pig model. PloS ONE 15, e0239391 (2020).

    Article  CAS  Google Scholar 

  8. Kalla, D. et al. The missing link: Cre pigs for cancer research. Front. Oncol. 11, 755746 (2021).

    Article  Google Scholar 

  9. Wang, K. et al. Cre-dependent Cas9-expressing pigs enable efficient in vivo genome editing. Genome Res. 27, 2061–2071 (2017).

    Article  CAS  Google Scholar 

  10. Rieblinger, B. et al. Cas9-expressing chickens and pigs as resources for genome editing in livestock. Proc. Natl Acad. Sci. USA. 118, e2022562118 (2021).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Technical University of Munich, Munich, Germany

    Dieter Saur & Angelika Schnieke

Authors
  1. Dieter Saur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angelika Schnieke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angelika Schnieke.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saur, D., Schnieke, A. Porcine cancer models for clinical translation. Nat Rev Cancer 22, 375–376 (2022). https://doi.org/10.1038/s41568-022-00467-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41568-022-00467-0

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer